Skip to content
Screener

Odyssey Therapeutics ODTX Price / book

Price / book at other companies

Southern Company logo
Southern CompanySO
2.7×0.0×
Synopsys logo
SynopsysSNPS
3×-3.8×
Northern Trust logo
Northern TrustNTRS
2×+0.5×
Dycom Industries logo
Dycom IndustriesDY
6.6×+2.8×
Nucor logo
NucorNUE
1.8×+0.4×
Berkshire Hathaway logo
Berkshire HathawayBRK.A
1.5×-0.3×

Other financials

Income statement

See full
Revenue--100%
Operating income-$55.5M-32.3%
Net income-$52.8M-28.0%
EPS (diluted)-$1.74+94.1%

Balance sheet

See full
Cash & equivalents$82.0M-49.7%
Total debt$24.8M+8,175%
Total equity$421.2M+197%
Total assets$483.9M—

Cash flow

See full
Operating cash flow-$34.5M-0.7%
CapEx$186.0K+541%
Free cash flow-$34.7M-1.2%

Valuation

See full
Market cap$1B+27.8%
Enterprise value$946.17M—
P/S348.8×—

Profitability

See full
Operating margin-6,129%—
Net margin-5,934%—
FCF margin-5,203.9%—

Returns & leverage

See full
Return on equity-8,434.8%—
Debt / equity0.1×—
Current ratio11.4×—

Where this comes from

Calculated from Odyssey Therapeutics’s reported figures.

market cap/total stockholders equity=2.1×

Based on the most recent quarter.

The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335822

FAQ

What is Odyssey Therapeutics's price / book?
Odyssey Therapeutics (ODTX) reported price / book of 2.1× in Q2 2026.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Odyssey Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude